Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Multiomics Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The multiomics market experienced substantial expansion recently. Projecting forward, its value is expected to increase from $3.85 billion in 2025 to $4.52 billion in 2026, representing a compound annual growth rate of 17.6%. This upward trajectory during the past period can be linked to the increasing use of genomic sequencing, initial progress in transcriptomics technologies, enhanced accessibility of proteomic analysis tools, broader research into biomarker identification, and a surge in the generation of biological data.
The multiomics market is poised for substantial expansion, projected to reach $8.07 billion by 2030, reflecting a robust compound annual growth rate of 15.6%. This anticipated surge is propelled by several key factors, including significant progress in multiomics platform technology, escalating demand for tailored medical treatments, the increasing incorporation of artificial intelligence for data analysis, a greater presence of metabolomics in clinical environments, and the broadening utilization of multiomics within precision agriculture. During this forecast period, key trends that will shape the market include the heightened adoption of single-cell multiomics approaches, a more comprehensive integration of biological data across multiple layers, enhanced application of multiomics for the early detection of diseases, its expanded role in the drug discovery process, and the growing application of multiomics techniques in the field of agricultural genomics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp
Multiomics Market Growth Drivers And Industry Catalysts
The increasing need for tailored medical treatments is anticipated to stimulate the expansion of the multiomics sector. Personalized medicine, which focuses on adapting healthcare decisions and therapeutic interventions to individual patients by considering their unique genetic makeup, environmental exposures, and lifestyle choices, is gaining traction due to rapid technological progress, a growing desire for targeted treatments, and worldwide enhancements in healthcare systems. Multiomics plays a crucial role in this personalized approach by offering a comprehensive insight into a person’s genetic, molecular, and metabolic landscape, thereby empowering medical professionals to design treatments that align with the distinct biological profiles of each patient. As a testament to this trend, in February 2024, data from the Personalized Medicine Coalition indicated that the FDA sanctioned 16 new personalized therapies for individuals with rare conditions in 2023, a notable increase from the 6 approvals seen in 2022, further underscoring the growth trajectory of the multiomics market driven by the burgeoning demand for personalized medical solutions.
Multiomics Market Segment Analysis: What Are The Major Market Categories?
The multiomics market covered in this report is segmented –
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users
Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics
#Multiomics Market Trends Influencing Long-Term Demand
Leading entities within the multiomics sector are actively creating cutting-edge single-cell multiomics solutions designed to facilitate extensive research by scientists while meticulously preserving sample quality. These sophisticated platforms harness the power of artificial intelligence alongside multiple omics technologies, empowering users to effortlessly dissect and understand intricate biological information through advanced computational methods and machine learning. As an illustration, February 2023 saw the introduction of the BD Rhapsody HT Xpress, a high-capacity single-cell multiomics instrument by Becton, Dickinson, and Company, a prominent US medical technology firm. This novel system empowers researchers to isolate, tag, and examine individual cells with remarkable speed and volume, capable of processing up to eight times the cellular capacity of earlier BD single-cell analysis devices. The BD Rhapsody HT Xpress System guarantees complete sample retention, providing the adaptability to concurrently examine diverse sample types, varying cell sizes, and specific cell populations like stem cells or malignant cells, thereby accelerating researchers’ discovery process and deepening their comprehension.
Multiomics Market Leading Companies Driving Competitive Growth
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group
Access The Complete Multiomics Market Report:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report
Multiomics Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the multiomics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model